Interactions between dopamine and 5-HT3 receptors suggest new treatments for psychosis and drug addiction.

作者信息

Tricklebank M D

出版信息

Trends Pharmacol Sci. 1989 Apr;10(4):127-9. doi: 10.1016/0165-6147(89)90157-0.

DOI:10.1016/0165-6147(89)90157-0

PMID:2665244

Abstract

摘要

相似文献

Interactions between dopamine and 5-HT3 receptors suggest new treatments for psychosis and drug addiction.

Trends Pharmacol Sci. 1989 Apr;10(4):127-9. doi: 10.1016/0165-6147(89)90157-0.

5-HT3 receptor antagonists.

Drug Des Deliv. 1991;7(3):175-81.

Differential interactions of traditional and novel antiemetics with dopamine D2 and 5-hydroxytryptamine3 receptors.

Cancer Chemother Pharmacol. 1989;24(5):307-10. doi: 10.1007/BF00304763.

Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse.

Psychopharmacology (Berl). 1993;112(1 Suppl):S68-75. doi: 10.1007/BF02245009.

[New anti-psychotic drugs].

Presse Med. 1991 May 18;20(19):889-90.

[The pharmacologist facing the neuroleptics].

Encephale. 1991 Jun;17 Spec No 2:153-7.

[Psychopharmacology in a genomic perspective].

Ugeskr Laeger. 2005 May 16;167(20):2194-6.

Halopemide, a new psychotropic agent. Cerebral distribution and receptor interactions.

Pharm Weekbl Sci. 1985 Feb 22;7(1):1-9. doi: 10.1007/BF01962862.

5-HT6 receptor ligands and their antipsychotic potential.

Int Rev Neurobiol. 2011;96:141-61. doi: 10.1016/B978-0-12-385902-0.00006-1.

[Current concepts of the effects of neuroleptics].

Psychiatr Pol. 1990 Sep-Oct;24(5):28-37.

引用本文的文献

Vortioxetine vs. Other Antidepressants in Patients with Major Depressive Episode With or Without Substance Use Disorder.

Curr Neuropharmacol. 2021;19(12):2296-2307. doi: 10.2174/1570159X19666210113150123.

Selective catecholamine detection in living cells by a copper-mediated oxidative bond cleavage.

Chem Sci. 2019 Aug 14;10(37):8519-8526. doi: 10.1039/c9sc03338f. eCollection 2019 Oct 7.

Alleviating symptoms of withdrawal from an opioid.

Pain Ther. 2012 Dec;1(1):4. doi: 10.1007/s40122-012-0004-5. Epub 2012 Sep 20.

From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics.

Pharmacogenet Genomics. 2009 Mar;19(3):193-205. doi: 10.1097/FPC.0b013e328322e73d.

Diltiazem causes open channel block of recombinant 5-HT3 receptors.

J Physiol. 1999 Sep 15;519 Pt 3(Pt 3):713-22. doi: 10.1111/j.1469-7793.1999.0713n.x.

The effects of BRL 46470A, a novel 5-HT3 receptor antagonist, and lorazepam on psychometric performance and the EEG.

Br J Clin Pharmacol. 1993 Apr;35(4):395-9. doi: 10.1111/j.1365-2125.1993.tb04156.x.

The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.

Br J Pharmacol. 1995 Feb;114(4):851-9. doi: 10.1111/j.1476-5381.1995.tb13282.x.

5HT3 receptor antagonists do not block nicotine induced hyperactivity in rats.

Psychopharmacology (Berl). 1995 May;119(2):213-21. doi: 10.1007/BF02246163.

Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding.

Psychopharmacology (Berl). 1990;101(2):168-71. doi: 10.1007/BF02244121.

Further characterization, by use of tryptamine and benzamide derivatives, of the putative 5-HT4 receptor mediating tachycardia in the pig.

Br J Pharmacol. 1991 Jan;102(1):107-12. doi: 10.1111/j.1476-5381.1991.tb12140.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验